Alliancebernstein L.P. Chembio Diagnostics, Inc. Transaction History

Alliancebernstein L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$2.88 - $5.64 $148,320 - $290,460	-51,500 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$4.11 - $7.51 $103,161 - $188,501	-25,100 Reduced 32.77%	51,500 $245,000
Q2 2020 Aug 13, 2020	BUY	$3.18 - $15.54 $243,588 - $1.19 Million	76,600 New	76,600 $249,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.